During the past decade, Texas Digestive Disease Consultants - San Marcos conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Digestive Disease Consultants - San Marcos" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Gilead Sciences" with 3 trials sponsored, "Madrigal Pharmaceuticals, Inc." with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Intercept Pharmaceuticals" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Digestive Disease Consultants - San Marcos" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Galapagos NV" with 2 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Texas Digestive Disease Consultants - San Marcos" are "Ulcerative Colitis" (6 trials), "Crohn's Disease" (2 trials), "Non-Alcoholic Fatty Liver Disease" (2 trials), "Compensated Cirrhosis" (1 trials) and "NASH - Nonalcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Texas Digestive Disease Consultants - San Marcos" in a lesser frequency.

Most popular intervention types in "Texas Digestive Disease Consultants - San Marcos" are "Drug" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Filgotinib" (5 trials), "Etrasimod" (3 trials), "Placebo to match filgotinib" (2 trials) and "Resmetirom" (2 trials). Other intervention names were less common.

The vast majority of trials in "Texas Digestive Disease Consultants - San Marcos" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Texas Digestive Disease Consultants - San Marcos". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Texas Digestive Disease Consultants - San Marcos, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Digestive Disease Consultants - San Marcos, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".